KEQU in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with KEQU today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Kewaunee Scientific Corp supplies the furniture and equipment that research laboratories, schools, healthcare institutions and manufacturers need to fit out their facilities. Its core business is making custom laboratory furnishings, such as cabinets, work surfaces and fume hoods that remove fumes from work areas. Customers buy through purchase orders and contracts, either directly or through dealers, a national distributor and overseas subsidiaries.
Most revenue comes from its Lab Products Group, which includes Nu Aire, an acquired business making biological safety cabinets, incubators and ultralow freezers. Its smaller International business also handles laboratory design, engineering, construction and project management, taking projects from planning through testing and commissioning.
A substantial share of sales goes through two domestic dealers and the national stocking distributor. Demand depends on planned laboratory and healthcare construction and the progress of existing projects. Building delays can push back deliveries, while firm quoted prices leave Kewaunee exposed to labor and material cost increases before delivery. Project payments also take time to collect, with some money withheld until completion, so the company needs working capital while it fulfills orders.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Watch Kewaunee Scientific Corp’s laboratory and healthcare construction demand, project timing and demand for its expanded laboratory-equipment range following the Nu Aire acquisition: these drive its results.
Kewaunee Scientific Corp earningsThis company
Kewaunee’s report will show whether laboratory project progress and deliveries are turning into sales without eroding its gross margin.
Read sales growth alongside gross margin. Rising sales with a steady margin would indicate projects are progressing to delivery without labor and material costs incurred after firm-price quotes materially eroding profit. Slower sales or a falling margin would point to delayed customer construction or cost increases Kewaunee could not pass on. Together, these figures show whether laboratory projects are converting into sales that retain profit.